CME Telemetrix Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CME Telemetrix

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: GavinB who wrote ()	1/7/1998 8:04:00 PM
From: stephen	Read Replies (1) of 12

Has anyone taken a close look at this company lately? They are currently in the latter stages of Phase II testing on their non-invasive glucose monitor, and if the results are as good as the preliminaries than this stock should see significantly higher valuations. Apparently they are looking at filing for FDA in second quarter 98 with a desire to fast track the FDA process. Think about it. The worldwide diabetic population would take to this monitor (which is painless and fully non-invasive) in a huge way. The question I have is has anyone heard any updates or news from the company? This is potentially a great buying opportunity in the $6.50 range, if they can file for FDA by mid year and continue to get financial support from such biotech heavyweights as Abbott and Medisense. Any input on this company would be appreciated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext